Amedisys (NASDAQ: AMED) reported Q2 EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for the quarter came in at $314.2 million versus the consensus estimate of $307.11 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.